Conversely, it has been shown that glucose-6-phosphate dehydrogenase was increased in breast cancer cells that were undergoing ferroptosis induced by erastin, and this may be seen as a compensatory mechanism [50]. The gene discussed is G6PD; the disease is breast cancer.